Catalyst Brief

← Calendar

Readoutin 165d

Mylan Pharmaceuticals Inc — Transdermal system containing progestin

Phase 3 primary completion: Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential.

Date
May 2027
Type
Readout
Indication
Female Contraception

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.